For information on dosing, titration, administration instructions, and premedication for flu-like symptoms, please see the Dosing and Administration section and full Prescribing Information.
For information on dosing, titration, administration instructions, and premedication for flu-like symptoms, please see the Dosing and Administration section and full Prescribing Information.
Please see full Prescribing Information.
PLEGRIDY® (peginterferon beta-1a) is an interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
References: 1. PLEGRIDY Prescribing Information. Cambridge, MA: Biogen. 2. Reuss R. Pegylated interferon beta-1a in the treatment of multiple sclerosis—an update. Biologics. 2013;7:131-138. doi:10.2147/BTT.S29948.